We are committed to delivering reliable ODM-ready medical laser solutions for clinics and distributors. The Diode Laser 15 Watt 980nm For Hemorrhoids is a compact, powerful option that I stand behind for precise tissue coagulation with minimal downtime. It delivers stable 15W at 980nm, tuned for hemorrhoidal tissue, enabling faster relief and reductions in chair time. In collaboration with you, we tailor the system as an ODM partner, shaping the handpiece, software, and sterilization options to fit your Product line and branding. The console is compact, with fiber delivery, real-time power monitoring, and intuitive controls that shorten training. Safety is built in: skin-contact sensors, emergency shutoff, and automatic parameter checks. It meets international standards and works with standard consumables. Competitive pricing, reliable performance, and fast shipping help you grow your business. If you search for ODM-aligned, ready-to-market Product in the diode laser space, this solution checks all the boxes.
Global procurement buyers seeking a compact, reliable diode laser solution for hemorrhoid treatment can rely on a 15 Watt, 980 nm device that delivers precise ablation with controlled penetration and minimal collateral damage. Its fiber-delivered design enables easy integration into existing clinic systems or OEM platforms, while safety interlocks, thermal sensors, and sterilisable components promote consistent, compliant performance across diverse settings. From concept to delivery, the end-to-end package includes early engineering support, rigorous testing, scalable manufacturing, and global logistics. You gain full documentation for regulatory submissions, robust quality control under ISO/GMP standards, customizable packaging and labeling, predictable lead times, and reliable after-sales service. With flexible MOQ, configurable interfaces, and local service options, this solution is designed to accelerate time-to-market and reduce total cost of ownership for buyers worldwide.
| Phase | Objective | Key Metrics | Test Method | Target Value | Current Value | Status | Validation Date | Risk Level | Owner | Notes |
|---|---|---|---|---|---|---|---|---|---|---|
| Concept & Feasibility | Assess clinical need and technical viability of 980nm 15W diode laser for hemorrhoid therapy | Clinical need index, Technical feasibility score | Literature review, clinical input | Need index ≥ 70; Feasibility score ≥ 75 | Need 72; Feasibility 68 | In Progress | 2025-11-30 | Medium | R&D Lead | Prepare regulatory considerations early |
| Optical & Thermal Design | Achieve safe tissue interaction with controlled ablation and minimal collateral damage | Optical output stability, Thermal rise max | Bench laser tests, calorimetry | Stability < 2% RMS; Peak tissue temp < 45°C | 1.8% RMS; 42°C | In Progress | 2026-02-28 | Low | Optical Engineering | Enhance cooling design to handle 15W safely |
| Electrical & Control System | Build robust control and interlock system for safety | Interlock response time, EMI/EMC | Functional testing, EMC chamber | Response < 50 ms; EMI/EMC PASS | 38 ms; PASS | Completed | 2026-01-15 | Low | Electrical Engineering | Add watchdog timer |
| Safety & Regulatory Planning | Define safety architecture and regulatory roadmap (IEC 60601-1, 60601-2-22) | Hazard analysis coverage, Regulatory path identified | ISO 14971 process, gap analysis | 100% coverage; Path identified | 100%; Path identified | Completed | 2025-12-01 | Low | Regulatory Affairs | Prepare for 510(k) or CE submission |
| Biocompatibility & Sterilization | Ensure components meet biocompatibility and sterilization requirements | Biocompatibility tests, Sterilization compatibility | ISO 10993 tests, Sterilization validation | Pass all tests; Sterilization method validated | Pass; Sterilization validated | Completed | 2026-03-10 | Low | QA/QA | Use single-use sterile disposable handpiece |
| Prototyping & Bench Testing | Build functional prototype and verify performance | Prototype yield, Functional test pass rate | Lab bench tests, burn-in | Yield ≥ 95%; Pass ≥ 98% | 92%; 97% | In Progress | 2026-05-01 | Medium | R&D Lab | Tighten safety feature integration |
| Sterilization & Packaging | Define sterile barrier, packaging for delivery | Sterility assurance level, Packaging integrity | Sterility tests, package drop/compression | SAL 10^-6; packaging test pass | SAL 10^-6; Packaging test PASS | Completed | 2026-04-20 | Low | Packaging Engineering | Medical-grade packaging required |
| Manufacturing Readiness | Align manufacturing process with quality systems | Process capability, First-pass yield | Process capability study, pilot runs | Cp/Cpk > 1.33; FPY > 90% | 1.38; 92% | Completed | 2026-06-01 | Low | Manufacturing | Automation line proposed |
| Clinical Evaluation Plan | Define clinical evaluation protocol and metrics | Endpoints, sample size | Protocol design, clinician feedback | Endpoints defined; N ≥ 100 | Endpoints defined; N=120 | Completed | 2026-06-25 | Medium | Clinical Affairs | Monitor adverse events |
| Documentation & Quality System | Prepare regulatory documentation and QMS alignment | Dossier completeness, QMS readiness | Document checklists, internal audits | 100% complete; QMS audit ready | 100%; QMS ready | Completed | 2026-06-30 | Low | Document Control | Align with ISO 13485 |
| Pilot Production & Transfer | Run pilot production and transfer to full-scale line | Transfer success rate, Downtime | Pilot run, line balancing | >98% transfer; <1% downtime | 96%; 1.2% | In Progress | 2026-07-15 | Medium | Manufacturing | Finalize tooling |
| Commercial Delivery & Post-market | Prepare delivery, service, and post-market surveillance | On-time delivery, CAPA events | Logistics planning, surveillance plan | On-time ≥ 95%; CAPA ≤ 2 | On-time 88%; CAPA 3 | Not Started | 2026-09-01 | High | Commercial Ops | Establish field support network |